USP28 and lung carcinoma: Moreover, a remarkable decrease in USP28 and its substrates, such as c-Myc and Cyclin D1, was shown in lung cancer cells treated with SGH, suggesting that the anticancer function of SGH may be mediated by the downregulation of USP28 [14].